Genentech relaunches eye drug-implant that it pulled from market 2 years ago

The drug-device can be refilled twice a year — versus monthly injections into the eye — but Genentech said the first generation that was pulled from the market in 2022 didn’t meet its standards.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks